Advert - Daiichi-Sankyo – AUTH/3375/8/20

• Date posted
  02 August 2021
• Sanction
  Advertisement,
• Case number/s
  AUTH/3375/8/20 - Voluntary admission by Daiichi-Sankyo

For failing to publicly disclose transfers of value to healthcare organisations for three years in relation to therapy reviews, and in that regard breaching its undertaking given in Case AUTH/3285/12/19, Daiichi-Sankyo was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 9.1 - Failing to maintain high standards

Clause 24.1 - Failing to document and publicly disclose certain transfers of value to healthcare organisations

Clause 24.4 - Failing to disclose transfers of value annually within the first six months after the end of the calendar year in which the transfers of value were made

Clause 29 - Failing to comply with an undertaking